$SDST
Stardust Power Inc.

2022 Q4 Form 10-K Financial Statement

#000121390023024925 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 2021
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $253.0K $1.984M $3.599M
YoY Change -1.17% -44.87% 35890.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $253.0K $1.984M $3.599M
YoY Change -1.17% -44.87% 35890.0%
Operating Profit -$1.984M -$3.599M
YoY Change -44.87%
Interest Expense $2.654M $100.0K $75.00K
YoY Change 37814.29% 33.33%
% of Operating Profit
Other Income/Expense, Net $467.0K $800.0K $8.229M
YoY Change -40.05% -90.28%
Pretax Income $2.868M $15.07M $4.705M
YoY Change 441.13% 220.28% -47150.0%
Income Tax
% Of Pretax Income
Net Earnings $2.868M $15.07M $4.705M
YoY Change 441.13% 220.28% -47150.0%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.08 $0.40 $125.5K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $101.0K $101.0K $842.0K
YoY Change -88.0% -88.0% 4110.0%
Cash & Equivalents $101.0K
Short-Term Investments
Other Short-Term Assets $8.000K $8.000K $183.0K
YoY Change -95.63% -95.63% -8.5%
Inventory
Prepaid Expenses $8.000K
Receivables
Other Receivables
Total Short-Term Assets $109.0K $109.0K $1.025M
YoY Change -89.37% -89.37% 5025.0%
LONG-TERM ASSETS
Property, Plant & Equipment $5.000M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $304.7M $304.7M $300.1M
YoY Change 1.53% 1.53%
Other Assets
YoY Change
Total Long-Term Assets $304.7M $304.7M $300.1M
YoY Change 1.53% 1.53% 142792.86%
TOTAL ASSETS
Total Short-Term Assets $109.0K $109.0K $1.025M
Total Long-Term Assets $304.7M $304.7M $300.1M
Total Assets $304.8M $304.8M $301.1M
YoY Change 1.22% 1.22% 130813.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $75.00K $75.00K $135.0K
YoY Change -44.44% -44.44%
Accrued Expenses $3.016M $3.016M $2.673M
YoY Change 12.83% 12.83% 26630.0%
Deferred Revenue
YoY Change
Short-Term Debt $785.0K $785.0K $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.876M $3.876M $2.808M
YoY Change 38.03% 38.03% 1237.14%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $10.97M $10.97M $23.42M
YoY Change -53.17% -53.17%
Total Long-Term Liabilities $10.97M $10.97M $23.42M
YoY Change -53.17% -53.17%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.876M $3.876M $2.808M
Total Long-Term Liabilities $10.97M $10.97M $23.42M
Total Liabilities $14.84M $14.84M $26.23M
YoY Change -43.41% -43.41% 12389.52%
SHAREHOLDERS EQUITY
Retained Earnings -$14.74M
YoY Change -41.36%
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$14.73M $289.9M $274.9M
YoY Change
Total Liabilities & Shareholders Equity $304.8M $304.8M $301.1M
YoY Change 1.22% 1.22% 130813.04%

Cashflow Statement

Concept 2022 Q4 2022 2021
OPERATING ACTIVITIES
Net Income $2.868M $15.07M $4.705M
YoY Change 441.13% 220.28% -47150.0%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$531.0K -$1.526M -$1.044M
YoY Change 318.11% 46.17%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$300.0M
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00 -$300.0M
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 385.0K $785.0K 301.9M
YoY Change -99.74% 1509230.0%
NET CHANGE
Cash From Operating Activities -531.0K -$1.526M -1.044M
Cash From Investing Activities 0.000 0.000 -300.0M
Cash From Financing Activities 385.0K $785.0K 301.9M
Net Change In Cash -146.0K $741.0K 822.0K
YoY Change 14.96% -9.85% 4010.0%
FREE CASH FLOW
Cash From Operating Activities -$531.0K -$1.526M -$1.044M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-39875
CY2022 dei Entity Registrant Name
EntityRegistrantName
GLOBAL PARTNER ACQUISITION CORP II
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
200 Park Avenue
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
32nd Floor
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10166
CY2022 dei City Area Code
CityAreaCode
(646)
CY2022 dei Local Phone Number
LocalPhoneNumber
585-8975
CY2022 dei Security12b Title
Security12bTitle
Class A ordinary shares
CY2022 dei Trading Symbol
TradingSymbol
GPAC
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
295200000 usd
CY2022 dei Auditor Name
AuditorName
WithumSmith+Brown, PC
CY2022 dei Auditor Location
AuditorLocation
New York
CY2022 dei Auditor Firm
AuditorFirmId
100
CY2022Q4 us-gaap Cash
Cash
101000 usd
CY2021Q4 us-gaap Cash
Cash
842000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8000 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
183000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
109000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1025000 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
304675000 usd
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
300075000 usd
CY2022Q4 us-gaap Assets
Assets
304784000 usd
CY2021Q4 us-gaap Assets
Assets
301100000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
75000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
135000 usd
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
785000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3016000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2673000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3876000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2808000 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
467000 usd
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
12920000 usd
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
10500000 usd
CY2021Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
10500000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
14843000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
26228000 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
304675000 usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
300000000 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 gpac Common Stock One Value
CommonStockOneValue
1000 usd
CY2021Q4 gpac Common Stock One Value
CommonStockOneValue
1000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14735000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25129000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-14734000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-25128000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
304784000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
301100000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1984000 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3599000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1984000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-3599000 usd
CY2022 us-gaap Interest Income Other
InterestIncomeOther
4600000 usd
CY2021 us-gaap Interest Income Other
InterestIncomeOther
75000 usd
CY2021 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
800000 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-12453000 usd
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-9029000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
15069000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
4705000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-25128000 usd
CY2022 gpac Accretion In Value Of Class A Ordinary Shares Subject To Redemption
AccretionInValueOfClassAOrdinarySharesSubjectToRedemption
4675000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
15069000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-14734000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
20000 usd
CY2021 gpac Proceeds From Sale
ProceedsFromSale
5566667 shares
CY2021 gpac Private Placement Warrants Per Shares
PrivatePlacementWarrantsPerShares
1.5
CY2021 gpac Fair Value Per Warrants
FairValuePerWarrants
1.41
CY2021 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
501000 usd
CY2021 gpac Accretion In Value Of Class A Ordinary Shares Subject To Redemption
AccretionInValueOfClassAOrdinarySharesSubjectToRedemption
30354000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
4705000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-25128000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
15069000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
4705000 usd
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
4600000 usd
CY2021 us-gaap Gain Loss On Investments
GainLossOnInvestments
75000 usd
CY2021 gpac Cost Of Issuing Warrants
CostOfIssuingWarrants
800000 usd
CY2022 gpac Change In Fair Value Of Warrant Liability
ChangeInFairValueOfWarrantLiability
12453000 usd
CY2021 gpac Change In Fair Value Of Warrant Liability
ChangeInFairValueOfWarrantLiability
9029000 usd
CY2022 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-175000 usd
CY2021 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
182000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-60000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
64000 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
343000 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2673000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1526000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1044000 usd
CY2021 us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
300000000 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
300000000 usd
CY2021 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
8350000 usd
CY2021 gpac Payment Of Underwriting Discounts
PaymentOfUnderwritingDiscounts
6000000 usd
CY2021 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
285000 usd
CY2022 gpac Advances And Payment Of Notes Payable
AdvancesAndPaymentOfNotesPayable
-785000 usd
CY2021 gpac Advances And Payment Of Notes Payable
AdvancesAndPaymentOfNotesPayable
199000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
785000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
301866000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
741000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
822000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
842000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
101000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
842000 usd
CY2021 gpac Deferred Underwriter Compensation
DeferredUnderwriterCompensation
10500000 usd
CY2021 gpac Offering Costs Included In Offering Costs Payable And Accrued
OfferingCostsIncludedInOfferingCostsPayableAndAccrued
70000 usd
CY2021Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
300000000 usd
CY2021Q1 gpac Trust Account
TrustAccount
300000000 usd
CY2022 us-gaap Interest Expense
InterestExpense
100000 usd
CY2022 gpac Shares Redeem Percentage
SharesRedeemPercentage
1 pure
CY2022 gpac Taxes Payable On Interest Earned Percentage
TaxesPayableOnInterestEarnedPercentage
0.80 pure
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5000001 usd
CY2022 us-gaap Business Combination Acquired Receivables Description
BusinessCombinationAcquiredReceivablesDescription
The amount in the Trust Account is initially funded at $10.00 per public Class A ordinary share ($300,000,000 held in the Trust Account divided by 30,000,000 public shares).
CY2022 gpac Description Of Business Combination
DescriptionOfBusinessCombination
The Company will have until January 14, 2024, the Termination Date, that may be proposed to and approved by the Company’s shareholders in the form of an amendment to the Company’s amended and restated memorandum and articles of association (the “Combination Period”). If the Company does not complete a Business Combination within this period of time, it shall (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the public Class A ordinary shares for a per share pro rata portion of the Trust Account, including interest earned on funds held in the trust account and not previously released to pay income taxes (less up to $100,000 of such net interest to pay dissolution expenses) and as promptly as possible following such redemption, dissolve and liquidate the balance of the Company’s net assets to its creditors and remaining shareholders, as part of its plan of dissolution and liquidation. The initial shareholders have entered into letter agreements with the Company, pursuant to which they have waived their rights to participate in any redemption with respect to their Founders Shares; however, if the initial shareholders or any of the Company’s officers, directors or affiliates acquire Class A ordinary shares in or after the Public Offering, they will be entitled to a pro rata share of the Trust Account with respect to the Class A ordinary shares so acquired upon the Company’s redemption or liquidation in the event the Company does not complete a Business Combination within the Combination Period.
CY2022Q4 us-gaap Investments And Cash
InvestmentsAndCash
101000 usd
CY2022 gpac Negative Working Capital
NegativeWorkingCapital
3767000 usd
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Concentration of Credit Risk: </i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates:</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022 gpac Total Offering Cost
TotalOfferingCost
17054000 usd
CY2022 gpac Underwriters Discount
UnderwritersDiscount
16500000 usd
CY2022 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
16254000 usd
CY2022 us-gaap Other Expenses
OtherExpenses
800000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5000001 usd
CY2022 gpac Public Shares
PublicShares
30000000 shares
CY2021 gpac Public Shares
PublicShares
30000000 shares
CY2022 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
300000000 usd
CY2022 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
14100000 usd
CY2022 gpac Offering Costs
OfferingCosts
16254000 usd
CY2022 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
30354000 usd
CY2022 us-gaap Temporary Equity Issue Period Increase Or Decrease
TemporaryEquityIssuePeriodIncreaseOrDecrease
300000000 usd
CY2022 gpac Accretion Of Carrying Value To Redemption Value Since Public Offering
AccretionOfCarryingValueToRedemptionValueSincePublicOffering
4675000 usd
CY2022Q4 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
304675000 usd
CY2021Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
30000000 shares
CY2021Q1 gpac Share Purchase Price
SharePurchasePrice
10
CY2022Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2022 gpac Redeemable Warrants
RedeemableWarrants
0.01
CY2022 gpac Ordinary Shares Equals Exceeds
OrdinarySharesEqualsExceeds
18
CY2022 gpac Underwriting Discount Percentage
UnderwritingDiscountPercentage
0.02 pure
CY2022 us-gaap Other Underwriting Expense
OtherUnderwritingExpense
6000000 usd
CY2022 gpac Deferred Underwriting Percentage
DeferredUnderwritingPercentage
0.035 pure
CY2022Q4 gpac Deferred Underwriting Fees Payable
DeferredUnderwritingFeesPayable
10500000 usd
CY2021Q1 gpac Founder Share Vesting Description
FounderShareVestingDescription
The Founder Shares are substantially identical to the Class A ordinary shares included in the Units sold in the Public Offering except that the Founder Shares automatically convert into Class A ordinary shares at the time of the Initial Business Combination, or at any time prior thereto at the option of the holder, and are subject to certain transfer restrictions, as described in more detail below, and the Founder Shares are subject to vesting as follows: 50% upon the completion of a Business Combination and then 12.5% on each of the attainment of Return to Shareholders (as defined in the agreement) exceeding 20%, 30%, 40% and 50%. Certain events, as defined in the agreement, could trigger an immediate vesting under certain circumstances. Founder Shares that do not vest within an eight-year period from the closing of the Business Combination will be cancelled.
CY2022 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
8350000 usd
CY2020Q4 gpac Aggregate Loan Amount
AggregateLoanAmount
300000 usd
CY2020Q4 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
1000 usd
CY2022Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
199000 usd
CY2022Q3 gpac Principal Amount
PrincipalAmount
2000000 usd
CY2022 gpac Outstanding Principal Balance
OutstandingPrincipalBalance
785000 usd
CY2022 us-gaap Sponsor Fees
SponsorFees
25000 usd
CY2022 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
300000 usd
CY2021 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
291000000 usd
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
15566667 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
15566667 shares
CY2022 us-gaap Results Of Operations Dry Hole Costs
ResultsOfOperationsDryHoleCosts
800000 usd
CY2022Q4 us-gaap Fair Value Concentration Of Risk Federal Funds Sold And Securities Borrowed Or Purchased Under Agreements To Resell
FairValueConcentrationOfRiskFederalFundsSoldAndSecuritiesBorrowedOrPurchasedUnderAgreementsToResell
300000000 usd
CY2022 gpac Common Stock In Total
CommonStockInTotal
550000000 shares
CY2022 us-gaap Business Combination Control Obtained Description
BusinessCombinationControlObtainedDescription
The Founder Shares are subject to vesting as follows: 50% upon the completion of a Business Combination and then an additional 12.5% on the attainment of each of a series of certain “shareholder return” targets exceeding 20%, 30%, 40% and 50%, as further defined in the agreement. Certain events, as defined in the agreement, could trigger an immediate vesting under certain circumstances. Founder Shares that do not vest within an eight-year period from the closing of the Business Combination will be cancelled. 
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.01 pure
CY2022Q4 us-gaap Fair Value Investments Entities That Calculate Net Asset Value Per Share Percent Equity Securities
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePercentEquitySecurities
0.01 pure
CY2022Q4 us-gaap Investment Company Gain Loss On Investment Not Meeting Guidelines
InvestmentCompanyGainLossOnInvestmentNotMeetingGuidelines
450000 usd
CY2022Q4 us-gaap Other Ownership Interests Value
OtherOwnershipInterestsValue
150000 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
usd
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
CY2022 gpac Payment Of Formation Costs Through Class B Ordinary Shares
PaymentOfFormationCostsThroughClassBOrdinaryShares
usd
CY2021 gpac Payment Of Formation Costs Through Class B Ordinary Shares
PaymentOfFormationCostsThroughClassBOrdinaryShares
usd
CY2022 gpac Cost Of Issuing Warrants
CostOfIssuingWarrants
usd
CY2022 us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2022 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
CY2022 gpac Payment Of Underwriting Discounts
PaymentOfUnderwritingDiscounts
usd
CY2022 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
usd
CY2022 gpac Deferred Underwriter Compensation
DeferredUnderwriterCompensation
usd
CY2022 gpac Offering Costs Included In Offering Costs Payable And Accrued
OfferingCostsIncludedInOfferingCostsPayableAndAccrued
usd
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001831979

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
gpac-20221231_pre.xml Edgar Link unprocessable
0001213900-23-024925-index-headers.html Edgar Link pending
0001213900-23-024925-index.html Edgar Link pending
0001213900-23-024925.txt Edgar Link pending
0001213900-23-024925-xbrl.zip Edgar Link pending
f10k2022ex10-7_globalpart2.htm Edgar Link pending
f10k2022ex31-1_globalpart2.htm Edgar Link pending
f10k2022ex31-2_globalpart2.htm Edgar Link pending
f10k2022ex32-1_globalpart2.htm Edgar Link pending
f10k2022ex32-2_globalpart2.htm Edgar Link pending
f10k2022ex4-6_globalpart2.htm Edgar Link pending
f10k2022_globalpart2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gpac-20221231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
gpac-20221231_cal.xml Edgar Link unprocessable
gpac-20221231_def.xml Edgar Link unprocessable
gpac-20221231_lab.xml Edgar Link unprocessable
f10k2022_globalpart2_htm.xml Edgar Link completed
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending